Placental Expression of NEMO Protein in Normal Pregnancy and Preeclampsia

Table 1

Clinical, hematological, and pregnancy characteristics of the study and control groups.

Parameter	Study group; (); Mean ± standard deviation	Control group; (); Mean ± standard deviation
WBC (10^3/μl)	10.4 ± 2.4	10.6 ± 2.2	0.560
RBC (10^6/μl)	4.1 ± 0.48	4.2 ± 0.41	0.376
HB (g/dl)	12.4 ± 2.3	12.4 ± 1.1	0.987
HCT (%)	35 ± 3.5	36.2 ± 2.6	0.099
MCV (fl)	85 ± 6.3	87 ± 5.2	0.072
MCHC (g/dl)	34 ± 2.4	34 ± 1.6	0.051
PLT (10^3/μl)	203 ± 60	222 ± 55	0.041
BMI (kg/m^2)	26 ± 3	25 ± 4	0.001
Newborn weight (g)	2371 ± 956	3401 ± 445	<0.001
Newborn high (cm)	48 ± 7	54 ± 3	<0.001
Maternal age at the time of delivery (years)	31 ± 6	32 ± 4	0.135
Week of delivery (week)	31 ± 2 (early preeclampsia)	39 ± 1	<0.001
	38 ± 2 (late preeclampsia)		0.001
Parameter	Study group; (%)	Control group; (%)
Primiparous	66 (68%)	35 (40%)	<0.001
Miscarriage	16 (16%)	15 (17%)	0.920
Male sex of the fetus	58 (60%)	40 (45%)	0.051

Legend: BMI, body mass index; WBC, white blood cells; RBC, red blood cells; HB, hemoglobin concentration; HCT, hematocrit; MCV, mean corpuscular volume; MCHC, mean corpuscular hemoglobin concentration; PLT, platelets; kg/m², kilograms/meter square; μl, microliter; g/dl, grams/deciliter; %, percent; fl, femtoliter; g, grams; cm, centimeter; , number of cases; — value calculated by Student’s t-test; — value calculated by chi² or chi² with Yates’s correction tests.